Multicentre prospective, randomised open-label, endpoint-blinded study to evaluate the safety and efficacy of propranolol for the prevention of stroke-associated pneumonia in patients with intracerebral haemorrhage (PROCHASE): rationale and design
The PROCHASE trial aims to generate clinical evidence regarding the safety and efficacy of propranolol in preventing SAP in patients with ICH.
Authors
- Arthur Liesz (ORCID: https://orcid.org/0000-0002-9069-2594)
- Jing‐Kun Yan (ORCID: https://orcid.org/0000-0001-9547-3772)
- Kaibin Shi (ORCID: https://orcid.org/0000-0001-7343-7498)
- Shunnan Ge (ORCID: https://orcid.org/0000-0003-1338-830X)
- Yanfang Liu (ORCID: https://orcid.org/0000-0003-1083-5880)
- Andreas Meisel (ORCID: https://orcid.org/0000-0001-7233-5342)
- Yan Qu (ORCID: https://orcid.org/0000-0001-5434-7390)
- Bin Gao (ORCID: https://orcid.org/0000-0002-5297-9199)
- Xingquan Zhao (ORCID: https://orcid.org/0000-0001-8345-5147)
- Fu‐Dong Shi (ORCID: https://orcid.org/0000-0002-9675-4637)
- Yuesong Pan
Institutions
- Capital Medical University (CN)
- Tianjin Medical University General Hospital (CN)
- LMU Klinikum (DE)
- Beijing Tian Tan Hospital (CN)
- Munich Cluster for Systems Neurology (DE)
- Charité - Universitätsmedizin Berlin (DE)
- Ludwig-Maximilians-Universität München (DE)
- Air Force Medical University (CN)
Publication Details
- Journal
- Stroke and Vascular Neurology
- Published
- 2024-12-31
- DOI
- https://doi.org/10.1136/svn-2024-003630
- Citations
- 2
- Primary Topic
- Intracerebral and Subarachnoid Hemorrhage Research
- Type
- article
- Field-Weighted Citation Impact
- 0.74
Funders
- National Natural Science Foundation of China